Vital signs and other observations used to detect deterioration in pregnant women: an analysis of vital sign charts in consultant-led UK maternity units by Smith, G.B. et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1016/j.ijoa.2017.03.002
Document Version
Peer reviewed version
Link to publication record in King's Research Portal
Citation for published version (APA):
Smith, G. B., Isaacs, R., Andrews, L., Wee, M. Y., van Teijlingen, E., Bick, D. E., & Hundley, V. (2017). Vital
signs and other observations used to detect deterioration in pregnant women: an analysis of vital sign charts in
consultant-led UK maternity units. INTERNATIONAL JOURNAL OF OBSTETRIC ANESTHESIA, 30, 44-51.
https://doi.org/10.1016/j.ijoa.2017.03.002
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 05. Apr. 2019
Accepted Manuscript
Original Article
Vital signs and other observations used to detect deterioration in pregnant wom-
en: an analysis of vital sign charts in consultant-led UK maternity units
G.B. Smith, R. Isaacs, L. Andrews, M.Y. Wee, E. van Teijlingen, D.E. Bick, V.
Hundley
PII: S0959-289X(17)30102-4
DOI: http://dx.doi.org/10.1016/j.ijoa.2017.03.002
Reference: YIJOA 2547
To appear in: International Journal of Obstetric Anesthesia
Received Date: 22 September 2016
Revised Date: 17 February 2017
Accepted Date: 2 March 2017
Please cite this article as: Smith, G.B., Isaacs, R., Andrews, L., Wee, M.Y., van Teijlingen, E., Bick, D.E., Hundley,
V., Vital signs and other observations used to detect deterioration in pregnant women: an analysis of vital sign charts
in consultant-led UK maternity units, International Journal of Obstetric Anesthesia (2017), doi: http://dx.doi.org/
10.1016/j.ijoa.2017.03.002
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers
we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and
review of the resulting proof before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
  
IJOA 16-00229 1 
ORIGINAL ARTICLE 2 
Vital signs and other observations used to detect deterioration in pregnant women: an 3 
analysis of vital sign charts in consultant-led UK maternity units 4 
G.B. Smith,a  R. Isaacs,a,b  L. Andrews,c  M.Y. Wee,a,d  E. van Teijlingen,e  D.E. Bick,e,f  V. 5 
Hundley,e on behalf of the Modified Obstetric Early Warning Systems (MObs) Research 6 
Group 7 
aCentre of Postgraduate Medical Research & Education (CoPMRE), Faculty of Health and 8 
Social Sciences, Bournemouth University, UK 9 
bDepartment of Anaesthesia, University Hospital Southampton, Southampton, UK 10 
cBournemouth University Clinical Research Unit (BUCRU), Faculty of Health and Social 11 
Sciences, Bournemouth, UK 12 
dDepartment of Anaesthesia, Poole Hospital NHS Foundation Trust, Poole, UK 13 
eCentre for Midwifery, Maternal & Perinatal Health, Faculty of Health and Social Sciences, 14 
Bournemouth University, UK 15 
fFlorence Nightingale Faculty of Nursing and Midwifery/Division of Women's Health, King’s 16 
College, London, UK 17 
 18 
Short title: Obstetric vital signs charts 19 
 20 
Correspondence to: Professor G B Smith, FRCA, FRCP, Centre of Postgraduate Medical 21 
Research & Education (CoPMRE), Faculty of Health and Social Sciences, Bournemouth 22 
University, Royal London House, Christchurch Road, Bournemouth, Dorset BH1 3LT, UK 23 
E-mail address: gbsresearch@virginmedia.com 24 
25 
  
ABSTRACT 26 
Background: Obstetric early warning systems are recommended for monitoring hospitalised 27 
pregnant and postnatal women. We decided to compare: (i) vital sign values used to define 28 
physiological normality; (ii) symptoms and signs used to escalate care; (iii) type of chart 29 
used; and (iv) presence of explicit instructions for escalating care. 30 
Methods: One hundred and twenty obstetric early warning charts and escalation protocols 31 
were obtained from consultant-led maternity units in the UK and Channel Islands. These data 32 
were extracted: values used to determine normality for each maternal vital sign; chart colour-33 
coding; instructions following early warning system triggering; other criteria used as triggers. 34 
Results: There was considerable variation in the charts, warning systems and escalation 35 
protocols. Of 120 charts, 89.2% used colour; 69.2% used colour-coded escalation systems. 36 
Forty-one (34.2%) systems required the calculation of weighted scores. Seventy-five discrete 37 
combinations of ‘normal’ vital sign ranges were found, the most common being: heart rate = 38 
50‒99 beats/min; respiratory rate = 11‒20 breaths/min; blood pressure, systolic = 100‒149 39 
mmHg, diastolic = <89 mmHg; SpO2 = 95‒100%; temperature = 36.0‒37.9oC; and AVPU 40 
assessment = Alert. Most charts (90.8%) provided instructions about who to contact 41 
following triggering, but only 41.7% gave instructions about subsequent observation 42 
frequency. 43 
Conclusion: The wide range of ‘normal’ vital sign values in different systems suggests a lack 44 
of equity in the processes for detecting deterioration and escalating care in hospitalised 45 
pregnant and postnatal women. Agreement regarding ‘normal’ vital sign ranges is urgently 46 
required and would assist the development of a standardised obstetric early warning system 47 
and chart. 48 
 49 
Keywords: Obstetric Emergency Team; Patient Safety; Standards of Care; Trigger Tools; 50 
Maternity; Women’s health.  51 
 52 
Introduction 53 
Early warning systems are recommended for monitoring the condition of hospitalised 54 
pregnant and postnatal women, to facilitate early detection and management of clinical 55 
deterioration.1-6 Some maternity units use systems designed primarily for the non-pregnant 56 
population.7 Others employ obstetric-specific systems comprising ‘calling criteria’ based on 57 
maternal vital sign measurements, symptoms and clinical signs, and conditions that 58 
  
commonly cause maternal morbidity and mortality.8-10 The regular measurement of a 59 
woman’s vital signs is a universal feature of obstetric early warning systems (ObsEWS) and 60 
choosing the correct normal ranges for measured variables is fundamental to their 61 
appropriate, safe and efficient use.11 However, publications suggest that ObsEWS vary with 62 
respect to the included vital signs and physiological values used to reflect normality.1-10  63 
Several types of ObsEWS exist. Some trigger a clinical response by a midwife, 64 
obstetrician or rapid-response team,12 when one or more abnormal observations are 65 
identified.3 Others trigger the same response when one or more markedly abnormal, or two or 66 
more mildly abnormal, observations are present.13,14 These systems are frequently used 67 
alongside charts featuring colour-coded shading to highlight markedly and mildly abnormal 68 
vital signs ranges, often shaded in red and yellow, respectively (Fig. 1).1,15 A third type of 69 
ObsEWS allocates points in a weighted manner, based on the derangement of a woman’s 70 
measured vital signs from pre-defined ‘normal’ ranges (Table 1).16,17 The sum of these points, 71 
known as the early warning score (EWS), is used to direct subsequent care. Some hospitals 72 
use combinations of the three systems. 73 
We decided to analyse early warning charts in routine use in consultant-led maternity 74 
units in the UK and Channel Islands to establish vital sign values used to determine normality 75 
in ObsEWS. We also identified other items used as triggers for escalating care (e.g. maternal 76 
symptoms, clinical signs and conditions), the type of vital signs chart used and the presence 77 
of explicit instructions for escalating care. 78 
 79 
Methods 80 
We wrote to all lead consultant anaesthetists registered with the Obstetric Anaesthetists’ 81 
Association (OAA) to request participation in an analysis of obstetric early warning charts, 82 
ObsEWS and associated escalation protocols used in consultant-led maternity units in the UK 83 
and Channel Islands. Contact details were provided by the OAA. We requested a copy of the 84 
vital signs/ObsEWS chart and associated escalation protocol used in each unit. Invitees were 85 
asked to send these by email or mail (a stamped-addressed envelope was provided). Invitees 86 
were assured that all data would remain confidential, and no hospital identifiers would be 87 
revealed during presentations or publications arising from the study. The study extended two 88 
earlier OAA-approved surveys (Nos. 76 & 135) into UK ObsEWS and escalation policies, 89 
undertaken by members of our group.8,9 90 
Non-responding leads/units were contacted again via telephone, follow-up letter and 91 
email. All were contacted a minimum of seven times (one telephone call, three letters and 92 
  
three emails). All documentation received by the study group was scanned, given a unique 93 
hospital identifier (No. 1‒194) and uploaded to a secure database for analysis. 94 
Two members of the research team (GS and RI) analysed each chart individually, and 95 
created a spreadsheet containing amalgamated data. Where opinions differed, charts were re-96 
checked to establish a single result for each data item.  97 
We documented whether each obstetric early warning chart was colour-coded, and if 98 
the chart identified: (i) who to call on ObsEWS triggering; and (ii) the frequency of vital 99 
signs monitoring expected after activation. We identified items used as triggers for escalation 100 
(i.e. vital signs, maternal symptoms, clinical signs, and conditions) from the chart alone, or, 101 
where necessary, from the chart and the associated EWS. For each maternal vital sign 102 
parameter studied (i.e. respiratory rate (RR), heart rate (HR), systolic blood pressure (sBP), 103 
diastolic blood pressure (dBP), mean blood pressure (mBP), temperature (T), AVPU (Alert-104 
Voice-Pain-Unresponsive) and oxygen saturation (SpO2)), we noted (a) whether it was used 105 
as a component of the ObsEWS, and (b) the values used to determine physiological normality 106 
on the vital signs chart or, if used, in the EWS. Similarly, we did the same for Glasgow Coma 107 
Score (GCS), maternal urine output and maternal oxygen administration. In addition, we 108 
noted whether other observations, criteria or abnormalities (e.g. presence of maternal 109 
proteinuria; uterine tone; maternal pain) were used as triggers in the early warning system. 110 
In line with guidance from the NHS Health Research Authority, this service 111 
evaluation did not require ethical review by an NHS or Social Care Research Ethics 112 
Committee or management permission through the NHS R&D office. Approval for the study 113 
was obtained from the OAA Surveys Subcommittee.  114 
 115 
Results 116 
A total of 194 lead obstetric anaesthetists were invited to contribute obstetric early warning 117 
charts and escalation protocols from their unit(s). Charts were returned by 127 (65.5%) but 118 
seven (3.6%) were unusable (e.g. poor quality photocopy, black and white photocopy where 119 
colour-coding was used). Of the 120 charts available for analysis, 88 were from England; 15 120 
from Scotland; 11 from Wales; 5 from Northern Ireland and 1 from the Channel Islands. 121 
There was considerable variation in the design of obstetric early warning charts. Of 122 
the 120 usable charts, 107/120 (89.2%) used colour in some way, but only 83/120 (69.2%) 123 
used a colour-coded escalation system. Two different systems were used to escalate care to 124 
more experienced staff, or to advise subsequent clinical actions. A colour-coded triggering 125 
system similar to that developed in Scotland and described in the 2007 Confidential Enquiry 126 
  
into Maternal and Child Health (CEMACH) report,1 was used in 79/120 (65.8%) (Fig. 1). A 127 
system that required staff to calculate an EWS from an aggregate weighted system was used 128 
in 41/120 (34.2%). Where a colour-coded system based on the presence of one or more 129 
abnormal observations (red/yellow) was used (n=79), all except one (triggering score not 130 
stated) escalated care in the presence of either two yellow vital signs values or one red value. 131 
Where an aggregate weighted EWS was used to escalate care (n=41), the lowest aggregate 132 
score that triggered a bedside assessment by a doctor was 2 (4/41), 3 (15/41) 4 (15/41), 5 133 
(4/41) and 6 (3/41). 134 
Table 2 shows aggregated data for vital signs and related measurements used as a 135 
component of the trigger system: specifically, number of discrete ‘normal’ ranges in use 136 
across the units surveyed for each individual vital sign; lowest and highest value in any 137 
‘normal’ range; most commonly used ‘normal’ range; number of charts using the most 138 
commonly used ‘normal’ range; and whether the parameter was (i) used as a component of 139 
the triggering system, (ii) recorded but not used in the triggering system, or (iii) not recorded 140 
nor used. 141 
Variations in vital signs ranges used to define ‘normality’ for each of: HR, RR, sBP, 142 
dBP, SpO2 and T are shown in Appendix A. For HR, RR, sBP and SpO2, the most commonly 143 
chosen ‘normal’ range was used in only approximately 50% of units. The most commonly 144 
used combination of ‘normal’ ranges was that described in the CEMACH report,1 [HR, 50-99 145 
beats/min; RR, 11-20 breaths/min; sBP, 100-149 mmHg; dBP, <89 mmHg; SpO2, 95-100%; 146 
T, 36.0-37.9oC; and AVPU, A] however, this was used in only 16/120 (13.3%) units. Of the 147 
120 charts assessed, 102 (85%) included all seven vital signs that appear on the CEMACH 148 
chart (i.e. HR; RR; sBP; dBP; SpO2; T; AVPU). However, there were 75 discrete 149 
combinations of ‘normal’ ranges in use for these seven vital sign sets. We could find no 150 
evidence that any unit used a different ObsEWS for different stages of pregnancy or in the 151 
postpartum period.  152 
Table 3 shows the range of maternal symptoms and signs, and other clinical 153 
observations or measurements used as components of the ObsEWS reviewed. Whilst many of 154 
these supplementary observations formed part of a colour-coded chart and triggering system, 155 
some of these items contributed weightings to an aggregate EWS value. 156 
The baseline frequency for recording vital signs was not always recorded on the 157 
ObsEWS charts. Where recorded, it varied between units and was usually every 12 h or more 158 
frequent. Only 50/120 (41.7%) units provided instructions about changes in the vital sign 159 
measurement frequency once vital sign abnormalities were identified. In these circumstances, 160 
  
the subsequent vital signs measurement frequency was increased to a variable extent, usually 161 
to every 15-30 min. Usually, the frequency was determined by the degree of physiological 162 
derangement observed. Most charts (109/120; 90.8%) provided instructions about who to 163 
contact once the ObsEWS had triggered. 164 
 165 
Discussion 166 
We found a lack of agreement amongst the ObsEWS employed in consultant-led maternity 167 
units in the UK and Channel Islands regarding the most appropriate vital sign parameters to 168 
measure and vital sign values regarded as ‘normal’ values for each parameter. These169 
disparities probably exist because there is a paucity of knowledge regarding which vital 170 
signs, or combination of vital signs, are predictive of maternal deterioration during and after 171 
pregnancy, and this makes it difficult to obtain agreement on the necessary appropriate vital 172 
signs to measure routinely or to include in an ObsEWS. Similarly, although it is known that 173 
pregnancy alters maternal physiology,18 data are lacking regarding the normal maternal vital 174 
sign ranges for each stage of pregnancy, labour and the postpartum period.11  175 
Uncertainties arising from these knowledge gaps result in potential conflicts in 176 
maternal care. The vital sign normal ranges in several ObsEWS studied lie outside the 177 
recently published reference ranges in healthy term pregnant women undergoing caesarean 178 
section.19 More than 20% of units which include SpO2 in their ObsEWS use an SpO2 ‘normal’ 179 
range with a lower limit below 94%, i.e. below the British Thoracic Society recommended 180 
lower limit for target SpO2 during pregnancy.20 The normal ranges used for some parameters 181 
overlap with those used to highlight possible sepsis,21-23 which is especially concerning as 182 
sepsis is a significant direct cause of maternal mortality and morbidity.24 There are also 183 
examples of blood pressure ‘normal’ ranges overlapping with those used by the National 184 
Institute for Health and Care Excellence to define mild diastolic and severe systolic 185 
hypertension in pregnancy.25 In addition, parameters and normal values used in units in the 186 
UK and Channel Islands are also different to those being used in iMEWS in Ireland2 and in 187 
the Maternal Early Warning Criteria recommended in the USA.3 Data collection to establish 188 
a set of ‘normal’ vital signs ranges for pregnancy is currently underway11 and may lead to 189 
resolution of some of these uncertainties and disparities. 190 
Determination of a set of ‘normal’ vital signs ranges for pregnancy would facilitate 191 
development of a single validated ObsEWS for the UK and Channel Islands, although a 192 
particular challenge will be identification of suitable clinical outcomes against which 193 
ObsEWS can be validated. It would also be important to identify whether it is necessary or 194 
  
feasible to introduce a different ObsEWS for each phase of pregnancy. Introducing a 195 
different ObsEWS for each phase might be impractical since introducing just a single 196 
standardised ObsEWS can be challenging.26,27 197 
There was also variation in ObsEWS and vital signs charts used in the 120 units. Most 198 
units use a chart similar to that in the 2007 CEMACH report, employing a two-colour 199 
triggering system, but in many units the chart had been modified. The remainder used an 200 
aggregate weighted triggering system requiring calculation of an EWS. There was also 201 
variation concerning when and how to escalate care. Currently two-thirds of units use an 202 
ObsEWS that triggers when one or more markedly abnormal (red), or two or more mildly 203 
abnormal (yellow), observations occur. Superficially, these systems appear different to those 204 
based on aggregate weighted scoring systems. However, they can be considered aggregate 205 
weighted scoring systems with a triggering value of 2 (if red observations score 2 points and 206 
yellow score 1). Therefore, issues that require resolution are (i) agreement on the range of 207 
weightings (i.e., 0-2 or 0-3), and (ii) the aggregate EWS at which care escalation occurs. 208 
These questions can only be answered following collection and analysis of one or more large 209 
databases of maternal observations and outcomes. The design of a suitable ObsEWS chart is 210 
beyond the scope of our article. 211 
The 2007 CEMACH report indicated that there was “…an urgent need for the routine 212 
use of a national obstetric early warning chart, similar to those in use in other areas of 213 
clinical practice…” and suggested an auditable standard for such a chart to be developed and 214 
piloting started by the end of 2008.1 The 2011 publication by the Maternal Critical Care 215 
Working Group4 also recommended the introduction of a standard early warning system and 216 
chart for obstetrics. These guidelines are currently being updated and are expected to 217 
recommend the use of a standard ObsEWS incorporating six physiological parameters: RR, 218 
SpO2, T, sBP, dBP, and HR.28 These parameters would seem to have face validity because 219 
they are almost identical to those previously recommended by anaesthetists9 and midwives.10 220 
There is evidence that the majority of UK obstetric anaesthetists support the need for 221 
a standardised, validated tool to prompt midwives and medical staff to summon help.8,9 The 222 
benefits of standardising aspects of healthcare include reduced staff confusion and 223 
misunderstanding, consistency in clinical decision-making, reduced error rate, improved 224 
reliability, transferability across organisations and the opportunity for uniform staff 225 
training.29 Despite this and the validation of the CEMACH chart in 2012,13 there has been 226 
little progress in getting universal agreement on systems for detecting maternal deterioration 227 
in UK obstetric population. This may be because standardised systems are often perceived as 228 
  
a challenge to professional autonomy and jurisdiction.26 Midwives may be reluctant to adopt 229 
ObsEWS, because they can see no inherent value.10,27 Midwives also felt that clinical 230 
judgement was superior to the ObsEWS and that informing a doctor when the ObsEWS 231 
recommended escalation was unnecessary, if the midwife believed that the woman was 232 
well.27 We found no evidence that maternal concern about their perceptions of being at risk 233 
was included as a formal component of any ObsEWS triggering system.30 234 
The study has several strengths and weaknesses. It is the largest and most detailed 235 
study of ObsEWS to date. Two researchers used a common, objective, systematic approach 236 
to interrogate the early warning system charts independently, and analysis was not subject to 237 
influence by participating centres. The assistance of the contributing units contacted was 238 
essential. However, despite trying to contact leads/units multiple times, only 65.5% of units 239 
provided charts and a few were unusable. In addition, not all maternity units in the UK and 240 
Channel Islands are represented in the OAA database. Consequently, our data may be subject 241 
to non-response and volunteer bias, implying that the results may not necessarily reflect the 242 
actual use of ObsEWS in other centres. Nevertheless, the findings of variation in the design, 243 
type and structure of vital signs charts, ObsEWS and escalation systems in the units studied 244 
would be unchanged (other than in magnitude) by data from additional units. 245 
There is a lack of consensus regarding the vital sign values used to reflect 246 
physiological normality in ObsEWS used in consultant-led UK and Channel Island maternity 247 
units. Improving agreement would facilitate the introduction of a standardised national 248 
obstetric early warning chart, ObsEWS and escalation system, but this requires further 249 
research. Standardisation would improve the equality of maternal care across units. 250 
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Table 1 Typical obstetric early warning score 376 
 
3 2 1 0 1 2 3 
Breathing 
rate 
(breaths/min) 
<10 
  
10-14 15‒20 21‒30 >30 
SpO2 (%) <94 
  
>94 
   
Temperature 
(oC) 
 
<35.0 35.0–
35.9 
36.0‒38.0 
 
>38.0 
 
Systolic 
blood 
pressure 
(mmHg) 
<80 80‒90 91‒100 101‒140 141‒150 151‒159 >160 
Diastolic 
blood 
pressure 
(mmHg) 
   
<90 91‒100 101‒110 >110 
Heart rate 
(beats/min) 
<40 41‒50 51‒60 61‒100 101‒110 111‒130 >130 
Level of 
consciousness 
   
Alert Responds 
to Voice 
Responds 
to Pain 
Unconscious 
  377 
  
Table 2 Vital signs and other related measurements used to trigger early warning system 378 
escalation 379 
 
HR 
(beats/
min) 
RR 
(breaths/
min) 
sBP 
(mm
Hg) 
dBP 
(mm
Hg) 
mBP 
(mm
Hg) 
SpO
2 
(%) 
T (oC) AVP
U 
Use 
of O2 
Urin
e 
(mL/
h) 
GCS 
Numbe
r of 
discret
e 
‘norma
l’ 
ranges 
in use 
for 
each 
vital 
sign 
16 14 21 15 2 12 7 2 - - - 
Lowest 
value 
used in 
‘norma
l’ 
range 
40 8 80 40 0 90 35.0 A or 
V 
- - - 
Highes
t value 
used in 
‘norma
l’ 
range 
109 20 199 100 <124 100 38.0 A - - - 
Most 
comm
only 
used 
‘norma
l’ 
range 
50‒99 11‒20 100‒
149 
<89 <124 95‒1
00 
36.0‒
37.9 
A - >30 - 
Numbe
r using 
most 
comm
on 
range 
62/120  64/120  59/12
0  
88/11
7  
6/7 59/1
12  
74/11
9  
109/
112 
(97.3
%) 
- 13/4
8 
(27.1
%) 
1/1 
(100
%) 
 (51.7%
) 
(53.3%) (49.2
%) 
(75.2
%) 
(85.7
%) 
(52.7
%) 
(62.2
%) 
    
Used 
as 
compo
nent of 
escalat
ion 
system 
120/12
0 
120/120 120/1
20 
117/1
20 
7/120 112/
120 
119/1
20 
112/
120 
8/12
0 
(6.6
%) 
48/1
20 
(40.0
%) 
1/12
0 
(0.8
%) 
 (100%) (100%) 
 
(100
 
(97.5
(5.8
%) 
(93.3
%) 
(99.2
%) 
(93.3
%) 
   
  
%) %) 
Record
ed but 
not 
used 
0/120 0/120 0/120 0/120 14/12
0 
7/12
0 
1/120 0/12
0 
101/
120 
(84.2
%) 
55/1
20 
(45.8
%) 
0/12
0 
(0%) 
 (0%) (0%) (0%) (0%) (11.7
%) 
(5.8
%) 
(0.8%
) 
(0%)    
Not 
record
ed or 
used 
0/120 0/120 0/120 3/120 99/12
0 
1/12
0 
0/120 8/12
0 
11/1
20 
(9.2
%) 
17/1
20 
(14.2
%) 
119/
120 
(99.2
%) 
 (0%) (0%) (0%) (2.5
%) 
(82.5
%) 
(0.8
%) 
(0%) (6.7
%) 
   
Data are number (%) 380 
HR, heart rate; RR, respiratory rate; sBP, systolic blood pressure; dBP, diastolic blood pressure; mBP, 381 
mean blood pressure; T, temperature;  AVPU, (Alert-Voice-Pain-Unresponsive); GCS, Glasgow 382 
Coma Scale. 383 
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Table 3 Maternal symptoms and signs, and other clinical observations or measurements used as 385 
a component of obstetric early warning systems 386 
 
Recorded on chart 
- used as 
component of 
triggering system 
Recorded on chart 
- not used as 
component of 
triggering system 
Not recorded on 
chart nor used as 
component of 
triggering system 
Used as a 
component of 
aggregate EWS 
Maternal pain 
score 
76 (63.3%) 24 (20.0%) 20 (16.7%) 3 (2.5%) 
Characteristics of 
lochia 
68 (56.7%) 9 (7.5%) 43 (35.8%) 0 
Proteinuria 65 (54.2%) 12 (10.0%) 43 (35.8%) 7 (5.8%) 
Mother looks 
unwell 
63 (52.5%) 0 57 (47.5%) 2 (1.7%) 
Characteristics of 
amniotic fluid 
47 (39.2%) 5 (4.2%) 68 (56.7%) 1 (0.8%) 
Presence of 
nausea 
13 (10.8%) 25 (20.8%) 82 (68.3%) 0 
Drains/blood loss 12 (10.0%) 7 (5.8%) 101 (84.2%) 1 (0.8%) 
Uterine tone 11 (9.2%) 6 (5.0%) 103 (85.8%) 0 
Sedation level 3 (2.5%) 12 (10.0%) 105 (87.5%) 1 (0.8%) 
Briskness of 
neuroreflexes 
3 (2.5%) 7 (5.8%) 110 (91.7%) 0 
Level of epidural-
related motor 
block 
3 (2.5%) 5 (4.2%) 112 (93.3%) 0 
Level of epidural-
related sensory 
block 
2 (1.7%) 6 (5.0%) 112 (93.3%) 0 
Maternal blood 
glucose level 
2 (1.7%) 18 (15.0%) 100 (83.3%) 0 
Data are number (%) 387 
  388 
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Legends for figure 390 
Fig. 1 Obstetric early warning chart described in the CEMACH report of 2007 (Reproduced 391 
with permission of Dr.F Mcilveney, Forth Valley Royal Hospital) 392 
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 DOB:
Ward:


 
 
 
 
 
 

URINE  
 
 
 
 
 
 
 
 
 
 
 




 
 
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

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Highlights 395 
• Early warning systems used in UK consultant-led maternity units vary considerably 396 
• Many different vital sign ranges are used to define normal maternal physiology 397 
• Research is required to inform the normal vital sign ranges expected during pregnancy 398 
• Obstetric early warning systems and charts should be standardised 399 
 400 
